New help for dry eye
Emory Eye Center was the first academic center in Georgia to offer a new technology that can help patients who suffer from a certain type of dry eye syndrome (DES) beginning last December. The technology, LipiFlow: Thermal Pulsation ™ is a novel way to treat evaporative dry eye disease caused by Meibomian gland dysfunction (MGD). Opening and clearing the blocked oil glands allows the body to resume the natural production of lipids which are needed for a healthy tear film.
The result may eliminate the uncomfortable symptoms associated with evaporative dry eye, which include light sensitivity, foreign body sensation, eye fatigue, and eye burning.
For appropriate patients, the Lipiflow system helps not only the patient's vision and ocular surface issues, but also quality of life. Meibomian gland dysfunction is the most common cause of dry eye syndrome, and the new technology is a breakthrough treatment that addresses the underlying cause of dryness.
The treatment generally takes approximately 12 minutes total for both eyes and may last from nine to 15 months.
The LipiFlow Thermal Pulsation System applies heat to both inner eyelids, while at the same time applying gentle pressure to the outer eyelids causing release of lipid from the blocked Meibomian glands. The procedure is fast, virtually painless and is an out-patient procedure.
The treatment is FDA approved and in a clinical study, 79% of patients reported improvement of their dry eye symptoms, ranging from 10% to 100% improvement.